These strategies could enhance the clearance of toxic protein aggregates like amyloid-beta in Alzheimer’s disease or mutant huntingtin in Huntington’s disease, thus reducing neurodegeneration. The gene discussed is HTT; the disease is juvenile Huntington disease.